» Articles » PMID: 8714520

Interaction Between NG2 Proteoglycan and PDGF Alpha-receptor on O2A Progenitor Cells is Required for Optimal Response to PDGF

Overview
Journal J Neurosci Res
Specialty Neurology
Date 1996 Feb 1
PMID 8714520
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies on the NG2 chondroitin sulfate proteoglycan have shown that NG2 is expressed on A2B5-positive O2A progenitor cells, which are known to respond to platelet-derived growth factor (PDGF). In the accompanying paper (Nishiyama et al.; J Neurosci Res 43:299-314, 1996) we show that on O2A progenitors in the embryonic and newborn rat brain, NG2 and PDGF alpha-receptor display an extensive co-localization which becomes less pronounced as the brain matures past the first postnatal week. The present communication describes the relationship between NG2 and PDGF alpha-receptor in vitro. NG2 and PDGF alpha-receptor are highly co-localized on A2B5-positive O2A cells isolated from neonatal rat cerebrum. Mimicking the situation in vivo, the level of expression of the two molecules and the extent of co-localization decline as these cells differentiate into O4-positive pre-oligodendrocytes. However, maintenance of the cells in a progenitor state by treatment with bFGF results in increased levels of both NG2 and PDGF alpha-receptor on the cell surface, suggesting that expression of the two molecules may be coordinately regulated. Furthermore, NG2 can be co-immunoprecipitated from radiolabeled O2A extracts with a rabbit antibody to PDGF alpha-receptor, indicating the presence of a molecular complex that includes NG2 and the receptor. Finally, antibody-patching and subsequent down-regulation of NG2 results in reduced expression of PDGF alpha-receptor and diminishes the proliferative response of the cells to PDGF. These findings suggest that correct co-expression of the NG2 proteoglycan and PDGF alpha-receptor on the surface of O2A progenitor cells is important for the cells' ability to respond effectively to the mitogenic stimulus of PDGF.

Citing Articles

Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration.

Bernstein H, Nussbaumer M, Vasilevska V, Dobrowolny H, Nickl-Jockschat T, Guest P Mol Psychiatry. 2024; 30(3):1102-1116.

PMID: 39639174 PMC: 11835740. DOI: 10.1038/s41380-024-02861-6.


Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Chen X, Habib S, Alexandru M, Chauhan J, Evan T, Troka J Cancers (Basel). 2024; 16(19).

PMID: 39409881 PMC: 11476251. DOI: 10.3390/cancers16193260.


Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system.

Bottero M, Pessina G, Bason C, Vigo T, Uccelli A, Ferrara G Front Immunol. 2024; 15:1393842.

PMID: 39136008 PMC: 11317297. DOI: 10.3389/fimmu.2024.1393842.


NG2/CSPG4 attenuates motility in mandibular fibrochondrocytes under serum starvation conditions.

Ahn S, Bagheri Varzaneh M, Zhao Y, Rozynek J, Ravindran S, Banks J Front Cell Dev Biol. 2023; 11:1240920.

PMID: 38020894 PMC: 10662293. DOI: 10.3389/fcell.2023.1240920.


Systemic and intrinsic functions of ATRX in glial cell fate and CNS myelination in male mice.

Rowland M, Jiang Y, Shafiq S, Ghahramani A, Pena-Ortiz M, Dumeaux V Nat Commun. 2023; 14(1):7090.

PMID: 37925436 PMC: 10625541. DOI: 10.1038/s41467-023-42752-y.